Status:
COMPLETED
Effect of Vitamin D Supplementation on Metabolic Parameters of Patients With Psoriasis
Lead Sponsor:
Pontificia Universidad Catolica de Chile
Conditions:
Psoriasis
Metabolic Syndrome
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether supplementation with oral vitamin D (cholecalciferol) improves metabolic parameters in patients with moderate to severe psoriasis.
Eligibility Criteria
Inclusion
- Clinical diagnosis of moderate to severe psoriasis.
- Being treated with methotrexate with stable doses for al least 1 month.
Exclusion
- Phototherapy within the past 2 months.
- History of psoriatic arthritis, rheumatoid arthritis, type 1 diabetes mellitus or inflammatory bowel disease.
- Use of vitamin d supplements or fish oil supplements in the past 2 months.
- Use of hypolipidemic drugs, hypoglycemic drugs, glucose sensitizers, oral corticosteroids, orlistat, cholestyramine, phenobarbital or phenytoin within the past 2 months.
- Pregnancy or lactation.
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2015
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT02271971
Start Date
October 1 2014
End Date
October 1 2015
Last Update
November 4 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pontificia Universidad Católica de Chile
Santiago, Santiago Metropolitan, Chile